Listen "No Such Thing as "Clone and Go""
Episode Synopsis
Merck’s Joseph McDonnell and Jeffrey Timmons discuss the company’s spinoff of Organon, how the separate organizations are creating value for all stakeholders, and why they’re excited about the role of technology in streamlining the regulatory process.
More episodes of the podcast Calyx Cafe
Three Ingredients to Successful Partnerships
27/10/2022
Craig Mooney: Data, Data, Who Owns the Data?
09/08/2022
Physician-centricity
22/09/2022
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.